Skip to main content
. 2015 Aug;4(4):465–474. doi: 10.3978/j.issn.2218-6751.2015.07.17

Figure 1.

Figure 1

Survival of patients with documented wildtype EGFR non-small cell lung cancer in BR.21. (A) Progression-free survival (PFS); (B) overall survival (OS). EGFR, epidermal growth factor receptor; HR, hazard ratios.